These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16866770)

  • 1. Lamotrigine-induced severe manic switch.
    Desarkar P; Sinha VK
    Aust N Z J Psychiatry; 2006 Aug; 40(8):718. PubMed ID: 16866770
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
    Sagud M; Pivac N; Mustapic M; Nedic G; Peles AM; Kramaric M; Jakovljevic M; Muck-Seler D
    Psychopharmacology (Berl); 2008 May; 197(4):683-5. PubMed ID: 18246328
    [No Abstract]   [Full Text] [Related]  

  • 3. Lamotrigine-induced mania in adolescents.
    Moor S; Luty S; Joyce P
    Aust N Z J Psychiatry; 2007 Dec; 41(12):1013. PubMed ID: 17999274
    [No Abstract]   [Full Text] [Related]  

  • 4. International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression.
    J Clin Psychiatry; 2008 Oct; 69(10):1632-46. PubMed ID: 19192447
    [No Abstract]   [Full Text] [Related]  

  • 5. [In process].
    Müller JK; Leweke FM
    Med Monatsschr Pharm; 2016 Sep; 39(9):377-84. PubMed ID: 29956512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticonvulsants (carbamazepine, valproate, lamotrigine) in bipolar affective disorder].
    Puzyński S
    Psychiatr Pol; 2002; 36(6 Suppl):53-61. PubMed ID: 12647422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.
    Suppes T; Marangell LB; Bernstein IH; Kelly DI; Fischer EG; Zboyan HA; Snow DE; Martinez M; Al Jurdi R; Shivakumar G; Sureddi S; Gonzalez R
    J Affect Disord; 2008 Dec; 111(2-3):334-43. PubMed ID: 18358540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic mood destabilization: case vignettes.
    Swann AC
    CNS Spectr; 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4. PubMed ID: 20173695
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder".
    Pae CU; Han C; Marks DM; Patkar AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):595-6. PubMed ID: 18061327
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychosis, delirium, or manic switch due to lamotrigine?
    Selek S; Savas HA
    Epilepsy Behav; 2007 Nov; 11(3):476; author reply 477. PubMed ID: 17904908
    [No Abstract]   [Full Text] [Related]  

  • 13. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.
    Kessing LV; Hellmund G; Andersen PK
    J Psychopharmacol; 2012 May; 26(5):644-52. PubMed ID: 21948935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
    Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinations during lamotrigine treatment of bipolar disorder.
    Uher R; Jones HM
    Am J Psychiatry; 2006 Apr; 163(4):749-50. PubMed ID: 16585461
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypomania induced by adjunctive lamotrigine.
    Margolese HC; Beauclair L; Szkrumelak N; Chouinard G
    Am J Psychiatry; 2003 Jan; 160(1):183-4. PubMed ID: 12505823
    [No Abstract]   [Full Text] [Related]  

  • 17. Tourette's symptoms provoked by lamotrigine in a bipolar patient.
    Seemüller F; Dehning S; Grunze H; Müller N
    Am J Psychiatry; 2006 Jan; 163(1):159. PubMed ID: 16390908
    [No Abstract]   [Full Text] [Related]  

  • 18. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine-induced rash after sun exposure.
    Bozikas V; Vartzopoulos D; Phocas C; Karavatos A; Kaprinis G
    Am J Psychiatry; 1999 Dec; 156(12):2015-6. PubMed ID: 10588424
    [No Abstract]   [Full Text] [Related]  

  • 20. Lamotrigine-induced facial tic in a pediatric bipolar disorder patient.
    Lu D; Lin X; Liu X; Su L
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):583-4. PubMed ID: 24138013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.